Cutting protein did not raise blood-cell autophagy in one trial

The human result did not follow the simple mechanism story

Autophagy is a cellular recycling process. In cells and animal models, nutrient sensing through mTORC1 helps regulate it. That biology can make a tidy headline: eat less protein, suppress mTORC1, increase autophagy, slow aging. The human trial tested only one link in that chain—and the measured link did not move in the predicted direction.

Researchers randomized 74 healthy adults to receive both diets in different orders. One provided 20% of energy from protein; the other provided 10%. Each period lasted four weeks, with a four-week washout between them. The menus were prescribed to maintain calculated energy balance, so this was not a fasting or calorie-restriction experiment.

The primary estimate crossed zero

After adjustment for period, sex, treatment sequence and baseline differences, the reduced-protein diet’s mean effect on autophagic flux was −8.46 ng LC3B-II/mg protein/hour relative to the average-protein diet. The 95% confidence interval ran from −24.06 to 7.14, and the p-value was 0.28.

That interval includes zero. The trial therefore did not detect the hoped-for average increase. It is still too strong to say protein reduction can never affect autophagy. The interval allows some smaller effects in either direction, and the assay sampled one cell pool, one fasting window and one short duration.

The denominator also matters. Seventy-four people were randomized, 63 completed both diet periods, and 61 met the adjusted primary-analysis requirements. The public registry’s final-sample field lists 63, which aligns with completers rather than everyone randomized. Keeping those counts separate avoids making the study look either larger or more complete than it was.

A dynamic flux assay is useful—and still bounded

The team measured LC3B-II accumulation in whole blood with and without lysosomal inhibition. That difference estimates autophagic flux: material moving through the pathway, rather than a static snapshot of one protein. Whole-blood handling also preserves the circulating environment better than isolating and feeding cells in culture.

But the measurement came from peripheral blood mononuclear cells. It does not report autophagy in muscle, liver, brain or heart. Bulk PBMC analysis could also miss a response confined to a particular immune-cell subtype. And because blood was collected after an overnight fast, the design could miss a temporary effect after eating or during another stress.

Secondary findings do not rescue a longevity claim

Lower circulating urea after the reduced-protein diet supported a real separation between the diets. The paper also reported small short-term reductions in body weight, muscle mass, fat-free mass and total body water. Fat mass, fasting glucose, insulin, LDL cholesterol, triglycerides, blood pressure, grip strength and self-reported health measures were broadly similar between diets.

Those comparisons were secondary and numerous. They were not evidence that losing lean mass was beneficial, evidence that the diet was harmful, or proof of equivalence for every metabolic outcome. Most importantly, none measured aging, disease events, disability, survival or years lived in good health.

Other human studies answer different questions

The paper discusses small studies that reported changes in static autophagy-related genes or proteins after longer low-protein diets or fasting-mimicking diets. Those signals are not direct contradictions. They used different populations, durations, energy conditions, tissues and assays. A transcript or protein abundance at one moment is not the same endpoint as dynamic autophagic flux.

This trial narrows the question usefully: a moderate, energy-balanced protein reduction for four weeks was not a robust way to raise fasting PBMC flux in these healthy adults. It does not settle whether a longer or more severe intervention, energy restriction, a different tissue, older age or metabolic disease would produce another result.

No diet recommendation follows

Participants were selected to be healthy and relatively young. The trial excluded many conditions and medicines that could affect metabolism or lysosomal biology, along with pregnancy, breastfeeding, peri- or post-menopause, smoking, unstable weight and eating patterns likely to affect autophagy. That selection improves control but narrows applicability.

The full report did not provide an adverse-event analysis from which long-term safety could be judged. Four weeks per diet cannot establish an optimal protein intake, effects on sarcopenia risk, or suitability for older adults and people with chronic disease. Protein decisions depend on total diet, age, health, activity and clinical context; this article is not a reason to start a restrictive diet.

Funding and disclosure context

BrightFocus Foundation grant A2021040S supported the work. The authors report that the funder had no role in study design, data collection, analysis, the decision to publish or manuscript preparation.

Two authors, Timothy Sargeant and Julien Bensalem, are listed as inventors on a related patent covering methods and products for assessing autophagic flux. That interest does not invalidate the result, but it is relevant because the paper’s central outcome depends on the assay.